Profil
Dr. Wilfred A. Jefferies is a Director & Chief Science Officer at MYND Life Sciences, Inc., a Chairman & Chief Scientific Officer at CAVA Healthcare, Inc., a Chairman & Chief Scientific Officer at Eyam Vaccines & Immunotherapeutics Ltd., a Professor at Michael Smith Laboratories and a Professor at University of British Columbia.
He is on the Board of Directors at MYND Life Sciences, Inc. Dr. Jefferies was previously employed as a Founder by Nevis Brands, Inc., a Chief Scientific Officer by Marker Therapeutics, Inc., and a Founder by Synapse Technologies, Inc. He received his undergraduate degree from the University of Victoria and a doctorate degree from Sir William Dunn School of Pathology.
Postes actifs de Wilfred Jefferies
| Sociétés | Poste | Début |
|---|---|---|
| MYND LIFE SCIENCES INC. | Fondateur | 06/07/2018 |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Michael Smith Laboratories
Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and training services | Corporate Officer/Principal | - |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables Extracts edible oil and produces flavored foods & products | Président | - |
Eyam Vaccines & Immunotherapeutics Ltd.
Eyam Vaccines & Immunotherapeutics Ltd. BiotechnologyHealth Technology Operates as a biotech company that designs and delivers therapies | Fondateur | - |
Anciens postes connus de Wilfred Jefferies
| Sociétés | Poste | Fin |
|---|---|---|
| NEVIS BRANDS INC. | Fondateur | - |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops therapeutic enzymes for blood-brain barrier intravenous injections | Fondateur | - |
| MARKER THERAPEUTICS, INC. | Président | 31/08/2009 |
Formation de Wilfred Jefferies
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables Extracts edible oil and produces flavored foods & products | Consumer Non-Durables |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops therapeutic enzymes for blood-brain barrier intravenous injections | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Victoria
University of Victoria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Michael Smith Laboratories
Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and training services | Commercial Services |
Nevis Brands, Inc.
Nevis Brands, Inc. BiotechnologyHealth Technology Engages in the research on the field of immunotherapy | Health Technology |
Sir William Dunn School of Pathology
Sir William Dunn School of Pathology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MYND Life Sciences, Inc.
MYND Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological pharmaceuticals | Health Technology |
Eyam Vaccines & Immunotherapeutics Ltd.
Eyam Vaccines & Immunotherapeutics Ltd. BiotechnologyHealth Technology Operates as a biotech company that designs and delivers therapies | Health Technology |
















